Covered recipient · General Payments record
CHERYL A HARTH
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
This page merges CMS profile IDs 18873, 8800662 — associated profiles published by CMS for the same covered recipient. See the colophon below.
General Payments · PY2018–2020
$33,753.12
- Reported across 125 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2020 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,335.00 | 2 |
| Food and Beverage | $508.43 | 7 |
By paying entity
PY2020 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SEAGEN INC. | $2,050.00 | 1 |
| EISAI INC. | $285.00 | 1 |
| Daiichi Sankyo Inc. | $122.22 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $114.71 | 1 |
| Rigel Pharmaceuticals, Inc. | $114.38 | 1 |
| Celgene Corporation | $109.32 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $18.08 | 1 |
| Merck Sharp & Dohme Corporation | $16.57 | 1 |
| Astellas Pharma US Inc | $13.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2020 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $13.15 | 01/30/2020 | Food and Beverage | Undisputed | 01/23/2026 | 718331501 | CMS |
| Bayer HealthCare Pharmaceuticals Inc. | $114.71 | 02/12/2020 | Food and Beverage | Undisputed | 01/23/2026 | 713642021 | CMS |
| Celgene Corporation | $109.32 | 01/14/2020 | Food and Beverage | Undisputed | 01/23/2026 | 728011289 | CMS |
| Daiichi Sankyo Inc. | $122.22 | 02/05/2020 | Food and Beverage | Undisputed | 01/23/2026 | 739474831 | CMS |
| Eisai Inc. | $285.00 | 03/06/2020 | Consulting Fee | Undisputed | 01/23/2026 | 751339419 | CMS |
| Merck Sharp & Dohme Corporation | $16.57 | 02/18/2020 | Food and Beverage | Undisputed | 01/23/2026 | 747705737 | CMS |
| Novartis Pharmaceuticals Corporation | $18.08 | 02/03/2020 | Food and Beverage | Undisputed | 01/23/2026 | 725791615 | CMS |
| Rigel Pharmaceuticals, Inc. | $114.38 | 01/24/2020 | Food and Beverage | Undisputed | 01/23/2026 | 752090183 | CMS |
| Seagen Inc. | $2,050.00 | 02/13/2020 | Consulting Fee | Undisputed | 01/23/2026 | 732441215 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020
- Generated from
- OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
- Merged CMS profile IDs
- 18873, 8800662
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.